Polaris Venture Partners V, L.p. - Net Worth and Insider Trading

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Phreesia Inc (PHR). Other recent insider transactions involving Phreesia Inc (PHR) include a net sale of 48,507 shares made by David Linetsky , a net sale of 11,711 shares made by Janet Gunzburg , and a net sale of 99,444 shares made by Evan Roberts .

In summary, during the past 3 months, insiders sold 51,069 shares of Phreesia Inc (PHR) in total and bought 0 shares, with a net sale of 51,069 shares. During the past 18 months, 424,237 shares of Phreesia Inc (PHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 424,237 shares.

Phreesia Inc (PHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Cardlytics Inc (CDLX). Other recent insider transactions involving Cardlytics Inc (CDLX) include a net sale of 368,506 shares made by Karim Saad Temsamani , a net sale of 69,591 shares made by Nicholas Hollmeyer Lynton , and a net purchase of 1,652,052 shares made by Clifford Sosin .

In summary, during the past 3 months, insiders sold 134,525 shares of Cardlytics Inc (CDLX) in total and bought 64,000 shares, with a net sale of 70,525 shares. During the past 18 months, 693,948 shares of Cardlytics Inc (CDLX) were sold and 1,733,207 shares were bought by its insiders, resulting in a net purchase of 1,039,259 shares.

Cardlytics Inc (CDLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 93,785 shares made by Mary Dibiase , a net sale of 330,550 shares made by Paula Ragan , and a net sale of 321,700 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 2,642 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 2,642 shares. During the past 18 months, 969,065 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 944,065 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 27,099 shares made by Mark T Iwicki , a net sale of 9,108 shares made by Romulus K Brazzell , and a net sale of 8,151 shares made by Todd Bazemore .

In summary, during the past 3 months, insiders sold 34,631 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 34,631 shares. During the past 18 months, 59,535 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,535 shares.

Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,231,332 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 15,516 shares, with a net purchase of 15,516 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 56,293 shares were bought by its insiders, resulting in a net purchase of 56,172 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , a net sale of 239 shares made by Michael Terrence Gibbs , and a net sale of 55 shares made by David B Elsbree .

In summary, during the past 3 months, insiders sold 55 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 55 shares. During the past 18 months, 483,515 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 483,515 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 300,000 shares made by Paul Schimmel , and a net purchase of 3,410 shares made by Jill Marie Broadfoot .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 425,000 shares were bought by its insiders, resulting in a net purchase of 423,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .

In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net purchase of 44,630 shares made by Redmile Group, Llc , a net sale of 18,777 shares made by Dulac Edward J Iii , and a net sale of 4,725 shares made by Yuan Xu .

In summary, during the past 3 months, insiders sold 633 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 633 shares. During the past 18 months, 393,126 shares of Fate Therapeutics Inc (FATE) were sold and 346,969 shares were bought by its insiders, resulting in a net sale of 46,157 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners V, L.p. made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 5,000,000 shares made by Adimab, Llc , and a net sale of 112,381 shares made by Terrance Mcguire .

In summary, during the past 3 months, insiders sold 0 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,112,381 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,112,381 shares.

Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.